SCHEMBL4657372

SCHEMBL4657372

Cc1ccc(O)cc1S(=O)(=O)NC1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 7/20 0.58
BRD2 P25440 2/20 0.58
BRD3 Q15059 2/20 0.58
LMNA P02545 2/20 0.58
HTT P42858 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
ALDH1A1 P00352 3/20 0.56
TP53 P04637 2/20 0.56
MCOLN3 Q8TDD5 1/20 0.54
HPGD P15428 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53
CASP1 P29466 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5513327 0.82 HTT (0.59) BRD4BRD2BRD3LMNAHTT
SCHEMBL19667044 0.80 MEN1 (0.67) BRD4BRD2BRD3HTTMEN1
SCHEMBL10641824 0.80 MEN1 (0.47) BRD4BRD2BRD3MEN1KMT2A
SCHEMBL9174539 0.79 CNR1 (0.46) LMNAMEN1KMT2AALDH1A1GAA
SCHEMBL128275 0.78 ALDH1A1 (0.64) BRD4BRD2BRD3LMNAHTT
SCHEMBL18739953 0.78 BRD4 (0.54) BRD4BRD2BRD3LMNAHTT
SCHEMBL4615963 0.77 ALDH1A1 (0.57) BRD4BRD2BRD3HTTMEN1
SCHEMBL8297692 0.77 TP53 (0.63) BRD4BRD2BRD3LMNAHTT
SCHEMBL14615140 0.77 TP53 (0.67) BRD4BRD2BRD3LMNAHTT
SCHEMBL6650873 0.77 ALDH1A1 (0.54) LMNAHTTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538070-B1 PHARMACEUTICAL COMPOSITION OF BENZENESULFONAMIDE DERIVATIVES FOR TREATMENT OF ADENOID CYSTIC CARCINOMA GONGWIN BIOPHARM CO LTD TAIWAN (TW) 2023-03-29 EP claimed
EP-3468547-B1 NOVEL BENZENESULFONAMIDE COMPOSITIONS FOR TREATMENT OF MALIGNANT PLEURAL EFFUSIONS GONGWIN BIOPHARM CO LTD TAIWAN (TW) 2021-10-06 EP claimed
EP-1389101-B1 TOLUENE SULFONAMIDE-CONTAINING ANTI-TUMOR COMPOSITION AND METHOD OF USE THEREOF PTS INTERNATIONAL INC (US) 2008-12-03 EP claimed
EP-1764388-B1 Composition, method of manufacturing a composition, heat-sensitive adhesive material, and information recording material RICOH KK (JP) 2008-10-29 EP claimed
EP-0894490-B1 Cosmetic compositions comprising a film-forming polymer OREAL (FR) 2002-01-16 EP claimed
EP-0012521-B1 VESICULAR RECORDING MATERIALS AND PROCESS FOR THEIR PRODUCTION BEXFORD LIMITED (GB) 1983-03-23 EP claimed
EP-1607452-B1 Coating composition for improving for improving surface properties DEGUSSA (DE) 2006-08-30 EP disclosed
EP-1607452-A1 Coating composition for improving for improving surface properties Degussa AG (DE) 2005-12-21 EP disclosed
EP-1396523-A1 Compacted flame retardant composition Clariant GmbH (DE) 2004-03-10 EP disclosed
EP-1396521-A1 Low-dust powdered fire retardant composition, method for production and use thereof, and flameproof polymer moulding material Clariant GmbH (DE) 2004-03-10 EP disclosed
EP-1396522-A1 Granular fire retardant composition Clariant GmbH (DE) 2004-03-10 EP disclosed
EP-0496120-B1 Self-extinguishing, halogen-free flame retardant moulding composition with improved fire resistance BASF AG (DE) 1996-02-28 EP disclosed
EP-0496120-A1 Self-extinguishing, halogen-free flame retardant moulding composition with improved fire resistance BASF Aktiengesellschaft (DE) 1992-07-29 EP disclosed
EP-0058331-B1 POLYAMIDE MOULDING COMPOUNDS BAYER AG (DE) 1985-06-12 EP disclosed
EP-0058331-A1 Polyamide moulding compounds BAYER AG (DE) 1982-08-25 EP disclosed
EP-0035669-A2 Aqueous dispersions and process for making them BAYER AG (DE) 1981-09-16 EP disclosed